Northwest Clinical Research Center

Improving Lives Through Research

Contact Us

425.453.0404

US FDA Approved Trials For Alzheimer’s

Northwest Clinical Research Center offers a variety of alzheimer’s studies evaluating potential medication that has been approved for investigation by the US FDA (Food and Drug Administration).

If you are interested in participating in a clinical research study, you can schedule a no cost, in-person evaluation to meet with our doctors and see if our studies are the right fit for you.

To participate in a clinical trial, please give us a call to schedule at 425-453-0404.

For specific details of our ongoing trials, please see the links below, provided by the National Library of Medicine:

 

Alzheimer's Disease

AACY: An Annual Dosing Study of Donanemab in Participants Who Completed Donanemab Study AACM

NCT07602582

TRIAL DETAILS

CN0120056: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimer’s Disease (ADEPT-4)

NCT06585787

TRIAL DETAILS

ITI-1284-201: A Multicenter, Randomized, Double-blind, Placebo-controlled, Flexible-dose Study to Assess the Efficacy, Safety, and Tolerability of ITI-1284 in Patients with Psychosis Associated with Alzheimer’s Disease

NCT06540833

TRIAL DETAILS

LHP588-201: A Randomized, Double-Blind, Placebo-Controlled Study of LHP588 in Subjects with P. gingivalis-Positive Alzheimer’s Disease
Trial Details

NCT06847321

TRIAL DETAILS

ML-007C-MA-221: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis

NCT06887192

TRIAL DETAILS

Study Evaluation Process

  • Screening: Determine eligibility and safety through medical examinations, questionnaires, and interviews.
  • Informed Consent: Receive detailed information about the trial, including risks and benefits.
  • Treatment: Receive investigational medication and placebo, and follow the trail protocol regarding current treatments and medications.
  • Monitoring: Close monitoring of conditions and side effects through check-ups, laboratory tests, EKG’s and assessments.

NWCRC in Bellevue, WA. Research and medical studies patient lounge.

CONTACT US

To be contacted about this study, fill out the contact form or call 425-453-0404.

This field is for validation purposes and should be left unchanged.
We complete all visits in person. Do you live within 50 miles of Bellevue, WA?(Required)


Are you interested in participating in clinical trials?(Required)


Please indicated which study you are interested in.(Required)